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FIBROMATOSIS OF THE MALE BREAST: A CASE
REPORT WITH IMMUNOHISTOCHEMISTRY STUDY
AND REVIEW OF THE LITERATURE.
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Carlos Francisco Erbolato Melo
Fibromatosis is an infiltrative proliferation of
fibroblastic and myofibroblastic cells with significant risk
for local recurrence, but no metastatic potential.1 It origi-
nates mainly from the fascia or aponeuroses of the abdomi-
nal wall muscles or from the muscles of the shoulders and
pelvic girdles.1 Fibromatosis is uncommon in the mammary
gland and accounts for less than 0.2% of all primary breast
lesions.2,3 Although several series of this condition have
been reported in women, mammary fibromatosis in men
is extremely rare.4–7 Despite its rarity, this condition may
mimic primary breast malignancy. In cases where suspi-
cious breast findings do not correlate with the usual diag-
nostic measures, such as those from fine-needle aspiration
or core needle biopsy, the diagnosis of a fibromatosis mim-
icking breast cancer should be considered in the differen-
tial diagnosis.8–9
We report the case of a 47-year-old man with mammary
fibromatosis. To the best of our knowledge, this is the sixth
case of fibromatosis reported in the male breast.4–7 The op-
timal management of breast fibromatosis in men is un-
known because of the rarity of the disease. A review of ar-
ticles published on breast fibromatosis was performed us-
ing the PUBMED-MEDLINE database with emphasis on
articles published during the last 10 years.
CASE REPORT
We present the case of a 47-year-old man who was ad-
mitted to the Outpatient Breast Oncology Service, Depart-
ment of Health of São Carlos, Brazil, with a 3-month his-
tory of a painless subcutaneous mass with rapid growth.
Clinical examination revealed an ill-defined mass located
in the upper inner quadrant of his left breast tissue meas-
uring of 3.5 cm in diameter. The mass was firm and was
fixed to the pectoral fascia and to skin. There was no axil-
lary or cervical lymphadenopathy or nipple discharge.
At ultrasound, the lesion manifested as an irregular,
hypoechoic mass with posterior acoustic shadowing, sug-
gestive of malignancy. Fine-needle aspiration cytology was
performed, but the result was inconclusive because the as-
pirate did not yield sufficient epithelial cells for diagno-
sis. The tumor was removed by en bloc resection with wide
excision, the greater pectoral muscle being spared. During
surgery the lesion was found to be firmly adherent to the
underlying pectoralis major. The appearance was that of
an infiltrative tumor, and the diagnosis of epithelial neo-
plasm was considered in the differential diagnosis. There
was no history of trauma to the chest wall, so that a fi-
brous reaction to trauma was not considered in the differ-
ential diagnosis.
The surgical specimen was fixed in 4% formalin. Se-
quential 3-mm sections were obtained throughout the speci-
men. Representative samples of the tumor were embedded
in paraffin, and histological sections of 4 µm obtained from
the paraffin-embedded blocks were stained with
hematoxylin-eosin. The histological sections stained with
hematoxylin-eosin showed a proliferation of spindle cells
without atypia forming sweeping or interlacing fascicles
(Figure 1). The cellularity varied from mild to moderate.
There was a variable amount of collagen predominantly
located in the center of the lesion. Mitotic figures were ab-
sent. At the periphery of the lesions, there were focally ir-
regular and infiltrating fingerlike projections extending into
the adjacent breast tissue. There was no inflammatory in-
filtration at the periphery of the lesion. Dilated vessels and
extravasated red cells were noted throughout the lesions.
For immunohistochemical staining, the paraffin-embed-
ded blocks were cut into 3-µm sections, deparaffinized, and
rehydrated. A standard avidin-biotin-peroxidase method was
used (Novostain Super ABC kit, Novocastra, Newcastle upon
Tyne, UK). The following primary antibodies were used: al-
pha smooth muscle actin (clone 1A4, Dako, Carpinteria, CA,
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1:100), bcl-2 (clone Bcl-2/100/D5, Novocastra, 1:50), CD10
(clone 56C6, Novocastra, 1:200), CD117 (c-kit oncoprotein)
(clone T595, Novocastra, 1:40), c-erbB-2 (clone CB11,
Novocastra, 1:300), cytokeratin AE1/AE3 (clone AE1 &
AE3, Dako, 1:1000), estrogen receptor (ER; clone 6F11,
Novocastra, 1:100), Ki67 (clone MM1, Novocastra, 1:150),
p53 (clone DO-7, Novocastra, 1:100), p63 (clone 4A4, Santa
Cruz, Palo Alto, CA, 1:100), progesterone receptor (PR;
clone 16, Novocastra, 1:150), S100 (polyclonal, Dako,
1:4000), and vimentin (clone V9, Dako, 1:100). After the
reactions, the sections were developed for 5 minutes with
3.3-diaminobenzidine tetrahydrochloride (DAB) in phos-
phate-buffered saline, pH 7.5, containing 0.036% hydrogen
peroxide. Light Mayer’s hematoxylin was applied as a coun-
terstain. The slides were then dehydrated in a series of
ethanols and mounted with Permount (Fischer, Fairlawn, NJ).
The immunohistochemistry study showed diffuse
positivity for vimentin (Figure 2), and focal positivity for
smooth muscle actin. The other markers were negative.
DISCUSSION
In spite of the abundance of reported cases and series
of extramammary fibromatosis in the literature, this is only
the sixth case reported in the male breast, and like previ-
ous descriptions, this patient presented with a history of a
palpable nontender breast mass with breast carcinoma-like
symptoms, such as fast growth and muscular infiltration,
skin infiltration and dimpling, nipple retraction,
mammographically indistinguishable from breast carci-
noma.10,11 Although tumor location was unusual for breast
carcinomas in men—the inner superior quadrant—and
breast malignancy is uncommon at this age, the presence
of breast cancer was the principal suspected clinical diag-
nosis.10 McKinnon et al12 noted that the correct diagnosis
of desmoid tumors was made preoperatively in only 50%
of cases and that, even after biopsy, the diagnosis was of-
ten confused with low-grade fibrosarcoma, confirming the
difficulty of diagnosis for this pathology.
Mammary fibromatosis presents macroscopically as a
dense, poorly vascularized, hard, rubbery, grayish-white
mass, and histologically, it is described as dense collagen-
ous material with intertwining bundles of spindle cells and
lacking epithelial components. These tumors do not
metastasize, have no capsule, infiltrate into local structures
(unlike fibrosarcomas), have normal mitotic characteristics,
and frequently recur after attempted surgical excision.1,3,13
The extra-abdominal sites most commonly involved are
the chest wall, shoulder girdle, inguinal region, and neck.1,3
Of this group, the chest wall is the most common site, usu-
ally involving the anterior muscles. Whether breast involve-
ment is an extension from a primary site within the fibro-
aponeurotic fascia or the pectoral muscle or whether it re-
sults from fibroblasts originating from within the breast
parenchyma is undetermined. However, fibromatosis aris-
ing within the breast parenchyma appears to represent a
separate entity from extramammary fibromatosis, although
both lesions may display a similar morphology. The
extramammary lesions display a higher propensity for lo-
cal recurrence compared to mammary fibromatosis.13,14
Mammary fibromatosis accounts for 4% of extra-abdomi-
nal fibromatosis cases.15
Figure 1. Histology of fibromatosis of the male breast showing a proliferation
of spindle cells with moderate cellularity and an edematous background
(hematoxylin-eosin, original magnification x200).
Figure 2. Immunohistochemical histology of fibromatosis of the male breast
showing diffuse positivity for vimentin (dark-stained cytoplasm) (original
magnification x400).
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The etiology of this lesion is still the subject of debate.
Trauma, particularly surgical trauma, has been emphasized
as an etiological factor. The occurrence of extramammary
fibromatosis in younger women, often during pregnancy,
the rapid tumor growth in women of childbearing age com-
pared to juvenile and postmenopausal women and men, and
spontaneous regression at menopause have suggested the
influence of sex steroid hormones in the growth of this
tumor.1,4–8
Since fibromatosis is an infiltrative proliferation of
fibroblastic and myofibroblastic cells, the positivity for
vimentin and smooth muscle actin was not surprising. Cu-
riously, fibromatosis in the breast differs from fibromato-
sis arising in other parts of the body due to its hormone
receptor profile. Although 30% of extramammary fibroma-
tosis are positive for estrogen receptors, only one of the
previously reported cases of mammary fibromatosis ex-
pressed hormonal receptors.16,17
Because of the consistent absence of immunoreactiv-
ity for estrogen and progesterone receptors in mammary
fibromatosis, a positive reaction for these receptors in
spindle cell neoplasms of the breast might be helpful in
excluding fibromatosis from its differential diagnoses17–
19.
 Another major concern about mammary fibromatosis
is the exclusion of the diagnosis of metaplastic carci-
noma, because spindle cell tumors with a myoepithelial
immunophenotype may be diagnosed as metaplastic car-
cinoma even with weak or absent cytokeratin expression.
In the present report, both epithelial (AE1/AE3) and
myoepithelial markers (CD14 and p63) were negative.21,22
Historically, wide excision has been the primary surgical
modality for fibromatosis and the initial treatment of choice
despite high local recurrence. However, due to the rarity of
fibromatosis, there are no randomized, controlled surgical tri-
als, and surgical treatment is most often dependent upon the
tumor location and size, which influences the potential for a
complete surgical resection.15 Other modalities of treatment,
such as radiotherapy, hormonal agents, anti-inflammatory
agents, and cytotoxic agents may be used in patients with
unresectable tumors or tumors that would require extensive
resection, including chest wall resection.14–23
The reported case demonstrates that fibromatosis in the
male breast may have features and a presentation that can
be confused with breast cancer. In situations where obvi-
ous breast changes and history do not correlate with rou-
tine diagnostic measures, the presence of an unusual breast
or chest wall tumor such as a fibromatosis should be con-
sidered, including this as part of the differential diagnosis.
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